MedTrace Logo

Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.

NCT06231849 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2024-01-30

No results posted yet for this study

Summary

This study will aim to investigate the gut microbiota in Egyptian patients with opioid use disorders and correlate microbiota bacterial abundance with clinical data.

Conditions

Interventions

DIAGNOSTIC_TEST

stool analysis

stool analysis to determine number of gut microbiota in subjects with opioid use and its effect on its intoxication.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2026-02-28
Completion
2026-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231849 on ClinicalTrials.gov